Conufen 18/27/36/54 18 mg, 27 mg, 36 mg, 54 mg Tablet
PDF Leaflet Revision Date: 21 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of ADHD in patients aged 6 to 65.
Dosage (summary)
Starting dose: 18 mg daily for children/adolescents; 18-36 mg for adults.
Onset of Action / Duration
Onset: 12 hours, Duration: 24 hours
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- MAO inhibitors
- Antihypertensives
- Serotonergic drugs
Contraindications
- Hypersensitivity to methylphenidate
- Glaucoma
- Pheochromocytoma
- Cardiovascular disorders
Common side effects
- Insomnia
- Anxiety
- Decreased appetite
- Headache
- Hypertension
Counselling Points
- Take in the morning with water
- Do not chew or crush tablets
- Monitor for psychiatric symptoms
Serious warnings
- Risk of sudden death in patients with cardiac abnormalities
- Potential for abuse and dependence
Important Disclaimer
The Conufen 18/27/36/54 18 mg, 27 mg, 36 mg, 54 mg Tablet professional information leaflet below is the property of Sandoz Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
